EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,649,000 | -69.1% | 219,000 | -74.1% | 0.22% | -73.0% |
| Q2 2022 | $5,330,000 | -18.0% | 846,000 | +8.0% | 0.83% | -0.8% |
| Q1 2022 | $6,499,000 | +355.8% | 783,000 | +266.7% | 0.84% | +277.5% |
| Q3 2021 | $1,426,000 | -21.6% | 213,519 | 0.0% | 0.22% | -20.7% |
| Q2 2021 | $1,819,000 | -3.8% | 213,519 | 0.0% | 0.28% | -17.9% |
| Q1 2021 | $1,890,000 | -17.2% | 213,519 | +15.0% | 0.34% | +13.3% |
| Q4 2020 | $2,282,000 | -40.7% | 185,719 | -60.7% | 0.30% | -85.2% |
| Q3 2020 | $3,847,000 | -35.4% | 472,558 | -23.8% | 2.04% | -39.9% |
| Q2 2020 | $5,954,000 | +116.1% | 620,266 | +53.1% | 3.39% | +5.9% |
| Q1 2020 | $2,755,000 | -10.0% | 405,207 | +97.3% | 3.21% | +8.6% |
| Q4 2019 | $3,060,000 | – | 205,407 | – | 2.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |